Akebia Therapeutics (AKBA) Goodwill & Intangibles (2018 - 2026)
Akebia Therapeutics (AKBA) posted quarterly Goodwill & Intangibles of $59.0 million for Q1 2026, little changed year-over-year from $59.0 million in Q1 2025, and little changed quarter-over-quarter from $59.0 million in Q4 2025.
Akebia Therapeutics (AKBA) Goodwill & Intangibles (2018 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Goodwill & Intangibles for 9 consecutive years, with $59.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Goodwill & Intangibles changed 0.0% year-over-year to $59.0 million; the TTM figure through Mar 2026 stood at $59.0 million (changed 0.0% YoY), while the FY2025 annual figure was $59.0 million, changed 0.0% from the prior year.
- Goodwill & Intangibles held at $59.0 million in Q1 2026 per AKBA's latest filing, from $59.0 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $158.2 million in Q1 2022 and bottomed at $59.0 million in Q2 2025.
- Historically, Goodwill & Intangibles has averaged $94.0 million across 5 years, with a median of $86.0 million in 2024.
- Annual changes were most pronounced in 2024 — Goodwill & Intangibles tumbled 37.9% — and 2025, when it changed 0.0%.
- Akebia Therapeutics' Goodwill & Intangibles stood at $131.1 million in 2022, then fell by 27.46% to $95.1 million in 2023, then sank by 37.9% to $59.0 million in 2024, then changed by 0.0% to $59.0 million in 2025, then changed by 0.0% to $59.0 million in 2026.
- Business Quant data shows AKBA's Goodwill & Intangibles at $59.0 million in Q1 2026, $59.0 million in Q4 2025, and $59.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Akebia Therapeutics | 249.25 Mn | 93.70 Mn | 38.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 59.04 Mn |
| Mar 31, 2026 | 59.04 Mn |
| Dec 31, 2025 | 59.04 Mn |
| Sep 30, 2025 | 59.00 Mn |
| Jun 30, 2025 | 59.00 Mn |
| Mar 31, 2025 | 59.04 Mn |
| Dec 31, 2024 | 59.04 Mn |
| Sep 30, 2024 | 68.01 Mn |
| Jun 30, 2024 | 77.02 Mn |
| Mar 31, 2024 | 86.03 Mn |
| Dec 31, 2023 | 95.09 Mn |
| Sep 30, 2023 | 104.05 Mn |
| Jun 30, 2023 | 113.11 Mn |
| Mar 31, 2023 | 122.12 Mn |
| Dec 31, 2022 | 131.08 Mn |
| Sep 30, 2022 | 140.14 Mn |
| Jun 30, 2022 | 149.15 Mn |
| Mar 31, 2022 | 158.16 Mn |
| Dec 31, 2021 | 167.13 Mn |
| Sep 30, 2021 | 172.24 Mn |